StreetInsider.com News Articles

Sanofi (SAN:FP) (SNY) PT Lowered to EUR82 at Morgan Stanley

Tue, 11 Aug 2026 04:37:18 -0400

Morgan Stanley analyst Sarita Kapila lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR82.00 (from EUR86.00) while maintaining a Equalweight rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR82 at Morgan Stanley

Tue, 11 Aug 2026 04:37:18 -0400

Morgan Stanley analyst Sarita Kapila lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR82.00 (from EUR86.00) while maintaining a Equalweight rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR82 at Morgan Stanley

Tue, 11 Aug 2026 04:37:18 -0400

Morgan Stanley analyst Sarita Kapila lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR82.00 (from EUR86.00) while maintaining a Equalweight rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR82 at Morgan Stanley

Tue, 11 Aug 2026 04:37:18 -0400

Morgan Stanley analyst Sarita Kapila lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR82.00 (from EUR86.00) while maintaining a Equalweight rating.

Form 6-K Sanofi For: Aug 06

Thu, 06 Aug 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260806/26877600.html

Form 6-K Sanofi For: Aug 06

Thu, 06 Aug 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260806/26877600.html

Form 6-K Sanofi For: Aug 06

Thu, 06 Aug 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260806/26877600.html

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at UBS

Fri, 31 Jul 2026 05:18:48 -0400

UBS analyst Matthew Weston lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR88.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at UBS

Fri, 31 Jul 2026 05:18:48 -0400

UBS analyst Matthew Weston lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR88.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at UBS

Fri, 31 Jul 2026 05:18:48 -0400

UBS analyst Matthew Weston lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR88.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at UBS

Fri, 31 Jul 2026 05:18:48 -0400

UBS analyst Matthew Weston lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR88.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at Citi

Fri, 31 Jul 2026 05:04:05 -0400

Citi analyst Graham Parry lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR82.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at Citi

Fri, 31 Jul 2026 05:04:05 -0400

Citi analyst Graham Parry lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR82.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at Citi

Fri, 31 Jul 2026 05:04:05 -0400

Citi analyst Graham Parry lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR82.00) while maintaining a Neutral rating.

Sanofi (SAN:FP) (SNY) PT Lowered to EUR78 at Citi

Fri, 31 Jul 2026 05:04:05 -0400

Citi analyst Graham Parry lowered the price target on Sanofi (SAN:FP) (NASDAQ: SNY) to EUR78.00 (from EUR82.00) while maintaining a Neutral rating.

Press Release: Sanofi’s half-year financial report for 2026

Thu, 30 Jul 2026 09:38:00 -0400

Sanofi’s half-year financial report for 2026

Paris, July 30, 2026. Sanofi announces that its half-year financial report for the period ending June 30, 2026, is now available online and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the US Securities and Exchange Commission (SEC) under form 6-K.

This document may be found on www.sanofi.com and downloaded from the “Investors” page, under the heading “Financial Reports and Other Publications”.